CCTN - MALE CONTRACEPTIVE - DMAU 28 DAY STUDY
$711,012N01FY2014HDNIH
University Of Washington, Seattle WA
Investigators
Abstract
Phase I Male Contraceptive Trial, Dimethylandrolone undecanoatehase (DMAU), shown in animal studies to inhibit spermatogenesis. Test single dose in man.
View original record on NIH RePORTER →